✦ LIBER ✦

A Modified Method for T-CR-T Diagram Construction Application to Polyethylene Glycol

✍ Scribed by R. Berlanga; J. Farjas; J. Saurina; J. J. Suñol

Book ID: 110287629
Publisher: Springer Netherlands
Year: 1998
Tongue: English
Weight: 304 KB
Volume: 52
Category: Article
ISSN: 0022-5215
DOI: 10.1023/a:1010158406598

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thermal Analysis of a Polyethylene Glyco

Thermal Analysis of a Polyethylene Glycol (PEG 4000): T-CR-T Diagram Construction

✍ J. J. Suñol; J. Farjas; R. Berlanga; J. Saurina 📂 Article 📅 2000 🏛 Springer Netherlands 🌐 English ⚖ 124 KB

Phenylalanine ammonia-lyase modified wit

Phenylalanine ammonia-lyase modified with polyethylene glycol: Potential therapeutic agent for phenylketonuria

✍ K. Ikeda; E. Schiltz; T. Fujii; M. Takahashi; K. Mitsui; Y. Kodera; A. Matsushim 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 86 KB

Improved phase method for determination

Improved phase method for determination of relative oscillator strengths: application to Cr II

✍ R. Sperger; T. Neger 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 577 KB

An efficient method for constructing a c

An efficient method for constructing a chimeric bacteriophage T4 to estimate the regulatory signals

✍ Toshitada Noguchi; Hideo Takahashi 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 460 KB

A novel method for the preparation of si

A novel method for the preparation of silver/chitosan-O-methoxy polyethylene glycol core shell nanoparticles

✍ A. M. Abdel-Mohsen, A. S. Aly, R. Hrdina, Ahmed T. El-Aref 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 684 KB

Polyethylene-glycol-modified interleukin

Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumors

✍ Vera Mattijssen; Lianne T. M. Balemans; Peter A. Steerenberg; Pieter H. M. de Mu 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 687 KB

Polyethylene glycol-modified recombinant human interleukin-2 (PEG-IL-2) represents a cytokine with prolonged circulatory half-life and increased antitumor activity as compared to recombinant interleukin-2 (rlL-2) after systemic administration. We studied whether PEG-IL-2 would also be advantageous i